Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05759780 · ClinicalTrials.gov registry record · NA
OCT Vibrography for Biomechanical Properties of Tissues
A NA study of Skin Diseases and Gingival Diseases, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT05759780: Recruiting NA study of Skin Diseases and Gingival Diseases, sponsored by Massachusetts General Hospital.
NCT05759780 is a NA study of Skin Diseases and Gingival Diseases that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 90 participants, below the 203-participant average among 14 other Skin Diseases trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05759780, a NA study of Skin Diseases and Gingival Diseases, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this study is to develop OCT Vibrography (aka OCT elastography) as a novel tool for measuring biomechanical properties of human tissues in vivo.
Primary Outcome
Frequency and severity of all treatment-related adverse events
Conditions Studied
Interventions
- DEVICE Optical imaging of the tissues
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2023-08-19 |
| Est. Completion | 2026-08-28 |
| Phase | NA |
What NCT05759780 shows while recruiting
NCT05759780 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 203-participant average among 14 other Skin Diseases trials with a reported enrollment target (56% lower).
The record links to 3 conditions, with Skin Diseases appearing as the primary indexed condition, and to 1 intervention - of which Optical imaging of the tissues is the first listed.
NCT05759780 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05759780 about?
NCT05759780 is a clinical study titled "OCT Vibrography for Biomechanical Properties of Tissues". The overall goal of this study is to develop OCT Vibrography (aka OCT elastography) as a novel tool for measuring biomechanical properties of human tissues in vivo.
What is the current status of trial NCT05759780?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2023-08-19. Estimated completion is 2026-08-28.
What conditions does trial NCT05759780 study?
This clinical trial studies the following conditions: Skin Diseases, Gingival Diseases, Cornea.
What interventions are being tested in trial NCT05759780?
The interventions under investigation include: Optical imaging of the tissues (DEVICE).
Who is sponsoring clinical trial NCT05759780?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05759780 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05759780's enrollment target sits among peer trials
90 8th of 14 higher than 7 of 14 other Skin Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Skin Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Teledermatology on Health Services Outcomes in the Department of Veterans Affairs
COMPLETED · NA
-
Joovvin' for Your Skin Health Study
COMPLETED · NA
-
Effects of Treatments on Atopic Dermatitis
RECRUITING · Phase 2
-
Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders
RECRUITING · Early Phase 1
-
Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)
RECRUITING · Phase 2
-
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI